These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 23583521)
21. Expression of Caveolin-1 reduces cellular responses to TGF-beta1 through down-regulating the expression of TGF-beta type II receptor gene in NIH3T3 fibroblast cells. Lee EK; Lee YS; Han IO; Park SH Biochem Biophys Res Commun; 2007 Jul; 359(2):385-90. PubMed ID: 17543885 [TBL] [Abstract][Full Text] [Related]
22. Human xylosyltransferase-I - a new marker for myofibroblast differentiation in skin fibrosis. Faust I; Roch C; Kuhn J; Prante C; Knabbe C; Hendig D Biochem Biophys Res Commun; 2013 Jul; 436(3):449-54. PubMed ID: 23747722 [TBL] [Abstract][Full Text] [Related]
24. Enhanced deposition of cartilage oligomeric matrix protein is a common feature in fibrotic skin pathologies. Agarwal P; Schulz JN; Blumbach K; Andreasson K; Heinegård D; Paulsson M; Mauch C; Eming SA; Eckes B; Krieg T Matrix Biol; 2013 Aug; 32(6):325-31. PubMed ID: 23507196 [TBL] [Abstract][Full Text] [Related]
25. Caveolin-1, transforming growth factor-beta receptor internalization, and the pathogenesis of systemic sclerosis. Del Galdo F; Lisanti MP; Jimenez SA Curr Opin Rheumatol; 2008 Nov; 20(6):713-9. PubMed ID: 18949888 [TBL] [Abstract][Full Text] [Related]
26. Involvement of caveolin-1 in fibronectin-induced mouse embryonic stem cell proliferation: role of FAK, RhoA, PI3K/Akt, and ERK 1/2 pathways. Park JH; Ryu JM; Han HJ J Cell Physiol; 2011 Jan; 226(1):267-75. PubMed ID: 20658539 [TBL] [Abstract][Full Text] [Related]
27. Caveolin-1 differentially regulates the transforming growth factor-β and epidermal growth factor signaling pathways in MDCK cells. Hsiao SC; Liao WH; Chang HA; Lai YS; Chan TW; Chen YC; Chiu WT Biochim Biophys Acta Gen Subj; 2024 Sep; 1868(9):130660. PubMed ID: 38871061 [TBL] [Abstract][Full Text] [Related]
28. Hyaluronan's Role in Fibrosis: A Pathogenic Factor or a Passive Player? Albeiroti S; Soroosh A; de la Motte CA Biomed Res Int; 2015; 2015():790203. PubMed ID: 26583132 [TBL] [Abstract][Full Text] [Related]
29. Interleukin-7 modulates extracellular matrix production and TGF-beta signaling in cultured human subconjunctival fibroblasts. Yamanaka O; Saika S; Ikeda K; Miyazaki K; Ohnishi Y; Ooshima A Curr Eye Res; 2006 Jun; 31(6):491-9. PubMed ID: 16769608 [TBL] [Abstract][Full Text] [Related]
30. Angiotensin II-induced pro-fibrotic effects require p38MAPK activity and transforming growth factor beta 1 expression in skeletal muscle cells. Morales MG; Vazquez Y; Acuña MJ; Rivera JC; Simon F; Salas JD; Alvarez Ruf J; Brandan E; Cabello-Verrugio C Int J Biochem Cell Biol; 2012 Nov; 44(11):1993-2002. PubMed ID: 22964022 [TBL] [Abstract][Full Text] [Related]
31. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model. Chujo S; Shirasaki F; Kawara S; Inagaki Y; Kinbara T; Inaoki M; Takigawa M; Takehara K J Cell Physiol; 2005 May; 203(2):447-56. PubMed ID: 15605379 [TBL] [Abstract][Full Text] [Related]
32. Impaired IL-17 signaling pathway contributes to the increased collagen expression in scleroderma fibroblasts. Nakashima T; Jinnin M; Yamane K; Honda N; Kajihara I; Makino T; Masuguchi S; Fukushima S; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H J Immunol; 2012 Apr; 188(8):3573-83. PubMed ID: 22403442 [TBL] [Abstract][Full Text] [Related]
33. Renin is an angiotensin-independent profibrotic mediator: role in pulmonary fibrosis. Montes E; Ruiz V; Checa M; Maldonado V; Melendez-Zajgla J; Montaño M; Ordoñez-Razo R; Cisneros J; García-de-Alba C; Pardo A; Selman M Eur Respir J; 2012 Jan; 39(1):141-8. PubMed ID: 21659414 [TBL] [Abstract][Full Text] [Related]
34. Augmented cytoplasmic Smad4 induces acceleration of TGF-beta1 signaling in renal tubulointerstitial cells of hereditary nephrotic ICGN mice with chronic renal fibrosis; possible role for myofibroblastic differentiation. Goto Y; Manabe N; Uchio-Yamada K; Yamaguchi-Yamada M; Inoue N; Yamamoto Y; Ogura A; Nagano N; Miyamoto H Cell Tissue Res; 2004 Feb; 315(2):209-21. PubMed ID: 14615933 [TBL] [Abstract][Full Text] [Related]
35. Dupuytren's Disease Is Mediated by Insufficient TGF-β1 Release and Degradation. Oezel L; Wohltmann M; Gondorf N; Wille J; Güven I; Windolf J; Thelen S; Jaekel C; Grotheer V Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894778 [TBL] [Abstract][Full Text] [Related]
36. Decreased caveolin-1 levels contribute to fibrosis and deposition of extracellular IGFBP-5. Yamaguchi Y; Yasuoka H; Stolz DB; Feghali-Bostwick CA J Cell Mol Med; 2011 Apr; 15(4):957-69. PubMed ID: 20345844 [TBL] [Abstract][Full Text] [Related]
37. Tissue stiffness, latent TGF-beta1 activation, and mechanical signal transduction: implications for the pathogenesis and treatment of fibrosis. Hinz B Curr Rheumatol Rep; 2009 Apr; 11(2):120-6. PubMed ID: 19296884 [TBL] [Abstract][Full Text] [Related]
38. The extracellular matrix and transforming growth factor-β1: Tale of a strained relationship. Hinz B Matrix Biol; 2015 Sep; 47():54-65. PubMed ID: 25960420 [TBL] [Abstract][Full Text] [Related]
39. Pathologic caveolin-1 regulation of PTEN in idiopathic pulmonary fibrosis. Xia H; Khalil W; Kahm J; Jessurun J; Kleidon J; Henke CA Am J Pathol; 2010 Jun; 176(6):2626-37. PubMed ID: 20395445 [TBL] [Abstract][Full Text] [Related]
40. Profibrogenic phenotype in caveolin-1 deficiency via differential regulation of STAT-1/3 proteins. Ryter SW; Choi AM; Kim HP Biochem Cell Biol; 2014 Oct; 92(5):370-8. PubMed ID: 25263949 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]